Breast cancer In trials, 0.6% of Saxenda-treated patients developed breast cancer compared to 0.2% of placebo-treated patients
The benefit of this is that this higher dose can be injected in one shot and the benefits of B12 supplementation may be felt sooner
Encapsulation into nanoparticles To enhance the pharmacological properties of the metal complex and provide cancer selectivity, Ru(II)-OH was incorporated into a polymer backbone that could self-assemble into tumor-targeting nanoparticles
Liraglutide has not been approved to treat Alzheimers
Mller TD, Clemmensen C, Finan B, DiMarchi RD, Tschp MH
Technique: Inject under the skin in the abdomen, thigh, or upper arm